|
1) Itoh K, Chiba T, Takahashi S, et al. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun. 1997; 236: 313-22
|
|
|
|
2) Ishii T, Itoh K, Takahashi S, et al. Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. J Biol Chem. 2000; 275: 16023-9
|
|
|
|
|
|
3) Jaiswal AK. Nrf2 signaling in coordinated activation of antioxidant gene expression. Free Radic Biol Med. 2004; 36: 1199-207
|
|
|
|
|
|
4) Cho HY, Reddy SP, Debiase A, et al. Gene expression profiling of NRF2-mediated protection against oxidative injury. Free Radic Biol Med. 2005; 38: 325-43
|
|
|
|
|
|
5) Cavarra E, Bartalesi B, Lucattelli M, et al. Effects of cigarette smoke in mice with different levels of alpha(1)-proteinase inhibitor and sensitivity to oxidants. Am J Respir Crit Care Med. 2001; 164: 886-90
|
|
|
|
|
|
6) Rangasamy T, Cho HY, Thimmulappa RK, et al. Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice. J Clin Invest. 2004; 114: 1248-59
|
|
|
|
|
|
7) Iizuka T, Ishii Y, Itoh K, et al. Nrf2-deficient mice are highly susceptible to cigarette smoke-induced emphysema. Genes Cells. 2005; 10: 1113-25
|
|
|
|
|
|
8) Ishii Y, Itoh K, Morishima Y, et al. Transcription factor Nrf2 plays a pivotal role in protection against elastase-induced pulmonary inflammation and emphysema. J Immunol. 2005; 175: 6968-75
|
|
|
|
|
|
9) Rangasamy T, Guo J, Mitzner WA, et al. Disruption of Nrf2 enhances susceptibility to severe airway inflammation and asthma in mice. J Exp Med. 2005; 202: 47-59
|
|
|
|
|
|
10) Betsuyaku T, Griffin GL, Watson MA, et al. Laser capture microdissection and real-time reverse transcriptase/ polymerase chain reaction of bronchiolar epithelium after bleomycin. Am J Respir Cell Mol Biol. 2001; 25: 278-84
|
|
|
|
|
|
11) Betsuyaku T, Senior RM. Laser capture microdissection and mRNA characterization of mouse airway epithelium: methodological considerations. Micron. 2004; 35: 229-34
|
|
|
|
|
|
12) Fuke S, Betsuyaku T, Nasuhara Y, et al. Chemokines in bronchiolar epithelium in the development of chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 2004; 31: 405-12
|
|
|
|
|
|
13) Adair-Kirk TL, Atkinson JJ, Griffin GL, et al. Distal airways in mice exposed to cigarette smoke: Nrf2-regulated genes are increased in Clara cells. Am J Respir Cell Mol Biol. 2008; 39: 400-11
|
|
|
|
|
|
14) MacNee W. Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2005; 2: 50-60
|
|
|
|
|
|
15) Rahman I. Oxidative stress in pathogenesis of chronic obstructive pulmonary disease: cellular and molecular mechanisms. Cell Biochem Biophys. 2005; 43: 167-88
|
|
|
|
|
|
16) Suzuki M, Betsuyaku T, Ito Y, et al. Down-regulated NF-E2-related factor 2 in pulmonary macrophages of aged smokers and COPD patients. Am J Respir Cell Mol Biol. 2008 Jun 19. [Epub ahead of print]
|
|
|
|
|
|
17) Goven D, Boutten A, Lecon-Malas V, et al. Altered Nrf2/Keap1-Bach1 equilibrium in pulmonary emphysema. Thorax. 2008; 63: 916-24
|
|
|
|
|
|
18) Malhotra D, Thimmulappa R, Navas-Acien A, et al. Decline in NRF2 eegulated antioxidants in COPD lungs due to loss of its positive regulator DJ-1. Am J Respir Crit Care Med. 2008; 178: 592-604
|
|
|
|
|
|
19) Bentley AR, Emrani P, Cassano PA. Genetic variation and gene expression in antioxidant-related enzymes and risk of chronic obstructive pulmonary disease: A Systematic Review. Thorax. 2008 Jun 19. [Epub ahead of print]
|
|
|
|
|
|
20) DeMeo DL, Hersh CP, Hoffman EA, et al. Genetic determinants of emphysema distribution in the national emphysema treatment trial. Am J Respir Crit Care Med. 2007; 176: 42-8
|
|
|
|
|
|
21) Molfino NA. Current thinking on genetics of chronic obstructive pulmonary disease. Curr Opin Pulm Med. 2007; 13: 107-13
|
|
|
|
|
|
22) Caramori G, Adcock I. Gene-environment interactions in the development of chronic obstructive pulmonary disease. Curr Opin Allergy Clin Immunol. 2006; 6: 323-8
|
|
|
|
|
|
23) Smith CA, Harrison DJ. Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema. Lancet. 1997; 350: 630-3
|
|
|
|
|
|
24) Vibhuti A, Arif E, Deepak D, et al. Genetic polymorphisms of GSTP1 and mEPHX correlate with oxidative stress markers and lung function in COPD. Biochem Biophys Res Commun. 2007; 359: 136-42
|
|
|
|
|
|
25) Matheson MC, Raven J, Walters EH, et al. Microsomal epoxide hydrolase is not associated with COPD in a community-based sample. Hum Biol. 2006; 78: 705-17
|
|
|
|
|
|
26) Yamada N, Yamaya M, Okinaga S, et al. Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema. Am J Hum Genet. 2000; 66: 187-95
|
|
|
|
|
|
27) Fu WP, Zhao ZH, Fang LZ, et al. Heme oxygenase-1 polymorphism associated with severity of chronic obstructive pulmonary disease. Chin Med J (Engl). 2007; 120: 12-6
|
|
|
|
|
|
28) Nakayama K, Kikuchi A, Yasuda H, et al. Heme oxygenase-1 gene promoter polymorphism and decline in lung function in Japanese men. Thorax. 2006; 61: 921
|
|
|
|
|
|
29) Chan-Yeung M, Ho SP, Cheung AH, et al. Polymorphisms of glutathione S-transferase genes and functional activity in smokers with or without COPD. Int J Tuberc Lung Dis. 2007; 11: 508-14
|
|
|
|
|
|
30) Bolt HM, Thier R. Relevance of the deletion polymorphisms of the glutathione S-transferases GSTT1 and GSTM1 in pharmacology and toxicology. Curr Drug Metab. 2006; 7: 613-28
|
|
|
|
|
|
31) Hopkinson NS, Li KW, Kehoe A, et al. Vitamin D receptor genotypes influence quadriceps strength in chronic obstructive pulmonary disease. Am J Clin Nutr. 2008; 87: 385-90
|
|
|
|
|
|
32) Imboden M, Downs SH, Senn O, et al. SAPALDIA Team. Glutathione S-transferase genotypes modify lung function decline in the general population: SAPALDIA cohort study. Respir Res. 2007; 8: 2
|
|
|
|
|
|
33) Yamamoto T, Yoh K, Kobayashi A, et al. Identification of polymorphisms in the promoter region of the human NRF2 gene. Biochem Biophys Res Commun. 2004; 321: 72-9
|
|
|
|
|